Main menu

Quantitative detection of cell free HPV DNA in liquid biopsy samples for cancer monitoring


Around 690,000 cancer cases are attributable to human papillomavirus (HPV) infection globally every year, most of them cervical (570,000) and oropharyngeal (42,000) cancers. Based on our current lab developed test*, that can quantitatively detect cell free HPV16/18 DNA in plasma samples, we strive to develop an assay in Kit format with matched performance that we will distribute directly to customers for use in sample preparation.

Download the PDF

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
English flag